Toggle navigation
Home
Topics
Topics
Clinical Systems
Clinical Systems
Clinical Systems
Clinical Systems
Disinfection and Decontamination Products
Obstetrics and Gynecology
Obstetrics and Gynecology
Oncology Systems
Specialties
Specialties
Specialties
Specialties
Sports Medicine
Transformation
Transformation
Transformation
Transformation
Ultrasound Devices
Wearable Devices
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
CXO Awards
About Us
US
US
EUROPE
APAC
Toggle navigation
Patient Monitoring Devices
Endoscopy
Dermatology Care
Medical Imaging Systems
Dental Care Devices
Sanitization Products and Equipment
Patient Monitoring Devices Latam
Orthopedic Devices and instruments Latam
Neurology Devices Latam
In Vitro Diagnostics Latam
Endoscopy Latam
Dental Care Devies Latam
Cardio Vascular Devices Latam
ENT Devices
Obstetrics and Gynecology
ENT Devices
Regenerative Medicine
Medical Equipment
Medical Imaging Systems
Patient Monitoring Devices
Regenerative Medicine
Cancer Care
Medical Equipment
Medical Device Design and Development
Medical Device Regulatory and Compliance
FemTech
Medical Device Design and Development Latam
Specialties
Transformation
Clinical Systems
Medical Aesthetics
Clinical Systems Latam
Specialties Latam
Clinical Systems
Specialties
Transformation Latam
Transformation
Medical Device Packaging
Transformation
Nephrology and Urology
Specialties
Clinical Systems
Wearable Devices
Vein Detection
Respiratory Care
Medical Device Design and Development
Neurology Devices
Disinfection and Decontamination Products
Endoscopy
Medical Equipment
Obstetrics and Gynecology
Surgical Devices and Instruments
Sports Medicine
Drug Delivery Solutions
Cardiovascular Devices
In Vitro Diagnostics
Medical Aesthetics
Patient Monitoring Devices
Dermatology Care
ENT Devices
Ultrasound Devices
Physiotherapy and Pain Management
Orthopedic Devices and Instruments
Biomechanics
Mobility Devices and Aids
Oncology Systems
Chronic and Long-Term Care
Dental Care Devices
Orthopedic Devices and instruments
In Vitro Diagnostic
Mobility Devices and Aids
Surgical Devices and Instruments
Drug Delivery Solutions
Physiotherapy and Pain Management
Medtech Startups
Cardio Vascular Devices
Surgical Devices and Instruments
Cardiovascular Devices
Physiotherapy and Pain Management
Drug Delivery Solutions
Medical Device Consulting
Orthopedic
Respiratory Devices
Medical Device Design and Development
Endoscopy
Medical Imaging Systems
In Vitro Diagnostics
Infection Control Solutions Canada
Physiotherapy and Pain Management Latam
Surgical Devices Latam
Medical Equipment
Regenerative Medicine
Cancer Care
Medical Equipment
Patient Monitoring Devices
Wearable Devices
Regenerative Medicine
MORE
Dec 2019 - Jan 20209Once again, spelling out that a patient is taking accountability for those aspects of his care not addressed in an online interaction seems reasonable to me. I think the liability concerns are overstated.Is the technology up to the task at hand?In the late 1990s, we (and many others) did painstaking clinical studies to empirically test whether a set of digital images is of sufficient quality to be a diagnostic tool in lieu of an in-person exam. There now exists a body of literature that demonstrates this equivalency, with the possible exception of some pigmented lesions. We also carefully examined the feasibility that patients could take their own, clinically accurate, facial images of acne. Are there other examples? Mental health providers routinely care for new patients and conduct follow up visits using video conferencing technology. There are probably a few other examples as well.To provide a quality care experience online without having met the patient in person, I contend that the following criteria would need to be met:1. Limit the interactions to problems that have a diagnostic data set that can be easily and reliably acquired by a consumer/patient.2. Assure that the patient is capable of understanding that the online interaction is problem specific and may carry risks, particularly for the omission of care involving other health problems.3. Assure that the treatment decisions for the specific condition at hand are algorithmic and do not require an authentic relationship (i.e., the problem is transactional or of low emotional value to both provider and patient).There are some things to work out, but there is good to be had by encouraging the thoughtful growth of teledermatology. For example, we need more patient-focused regulation and further study. We should also determine which symptoms are properly suited to online diagnosis versus the need for in-person care. The American Telemedicine Association (ATA) offers an accreditation process for DTC telemedicine. This is an important start, but probably not enough. DTC teledermatology could conceivably reduce costs and achieve equal or better quality of care for patients, without them having to leave their home. However, there are still questions around the diagnostic accuracy of teledermatology
<
Page 8
|
Page 10
>